<b>Format of the Annual Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''> <tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> ....
TATVA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Tatva Chintan Pharma Chem Ltd has filed its annual disclosure with BSE and NSE confirming that it does not qualify as a 'Large Corporate' under SEBI guidelines. The company has submitted the required Annexure XII-B2 format, which shows all borrowing-related fields as N.A. (Not Applicable) since the mandatory borrowing requirements through debt securities do not apply to the company. This is a routine compliance filing under SEBI's operational circulars for Large Corporates. The company confirms it falls below the threshold criteria that would classify it as a Large Corporate entity.
No impact on shareholders or stock price. This is a routine regulatory confirmation filing with no material implications for investors.